Evidence map›Paper›PMID 26289952›Full record

ArticleEmerging infectious diseases2015

Emerging Infections Program--State Health Department Perspective.

James L Hadler, Richard N Danila, Paul R Cieslak, James I Meek, William Schaffner, Kirk E Smith, Matthew L Cartter, Lee H Harrison, Duc J Vugia, Ruth Lynfield

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

James L Hadler
Richard N Danila
Paul R Cieslak
James I Meek
William Schaffner
Kirk E Smith
Matthew L Cartter
Lee H Harrison
Duc J Vugia
Ruth Lynfield

Funding

NCEZID CDC HHS 5U50-CK000195NCEZID CDC HHS U50 CK000195
6 · The paper itself

Abstract

The Emerging Infections Program (EIP) is a collaboration between the Centers for Disease Control and Prevention and 10 state health departments working with academic partners to conduct active population-based surveillance and special studies for several emerging infectious disease issues determined to need special attention. The Centers for Disease Control and Prevention funds the 10 EIP sites through cooperative agreements. Our objective was to highlight 1) what being an EIP site has meant for participating health departments and associated academic centers, including accomplishments and challenges, and 2) the synergy between the state and federal levels that has resulted from the collaborative relationship. Sharing these experiences should provide constructive insight to other public health programs and other countries contemplating a collaborative federal-local approach to collective public health challenges.

Indexed as

Public Health SurveillanceState GovernmentCommunicable Disease ControlCommunicable Diseases, EmergingHumansInterinstitutional RelationsUnited Statesacademic medical center emerging infections programsantimicrobial resistancebacteriacapacity buildingeducationEIPEmerging Infections Programenteric infectionsinfectious diseases emerginginfluenzalaboratoriesparasitesrespiratory infectionsrickettsiastaphylococcistreptococcisurveillancetrainingvector-borne infectionsviruseszoonoses

Identifiers

PMID26289952
PMCPMC4550133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.